Workflow
杭州园林(300649) - 2025 Q3 - 季度财报
2025-10-28 08:15
Financial Performance - The company's operating revenue for the third quarter was ¥26,961,845.57, a decrease of 42.30% compared to the same period last year[5] - Net profit attributable to shareholders was ¥15,606,425.70, an increase of 1,218.56% year-on-year[5] - The basic earnings per share reached ¥0.12, reflecting a growth of 1,100.00% compared to the previous year[5] - The company reported a 36.63% decline in operating revenue year-to-date, attributed to macroeconomic fluctuations and industry downturns[9] - Total operating revenue for the third quarter was CNY 95,871,359.28, a decrease of 36.8% compared to CNY 151,293,491.62 in the same period last year[23] - The net profit for the quarter was CNY 7,058,188.81, a significant recovery from a net loss of CNY 17,535,036.01 in the previous year[24] - The company reported an operating profit of CNY 9,125,836.08, compared to an operating loss of CNY 18,268,275.90 in the same quarter last year[24] - The total comprehensive income for the period amounted to 7,058,188.81, compared to a loss of 17,535,036.01 in the previous period[25] - Basic and diluted earnings per share were both 0.05, recovering from a loss of 0.13 in the previous period[25] Cash Flow and Assets - The net cash flow from operating activities was -¥110,099,138.88, a significant decline of 871.79% year-on-year[5] - Cash and cash equivalents decreased to CNY 83,685,928.29 from CNY 195,406,810.69, reflecting a decline of 57.2%[20] - Accounts receivable slightly decreased to CNY 204,872,067.35 from CNY 213,399,086.86, a reduction of 4.9%[20] - The total assets at the end of the reporting period were ¥902,856,057.75, down 9.85% from the end of the previous year[5] - The total assets of the company were CNY 902,856,057.75, down from CNY 1,001,521,131.15, indicating a decrease of 9.8%[20] - Total liabilities decreased to CNY 402,174,277.55 from CNY 501,276,709.31, a reduction of 19.7%[21] - Cash flow from operating activities showed a net outflow of -110,099,138.88, worsening from -11,329,499.03 in the previous period[28] - Cash inflow from operating activities totaled 194,267,218.64, down from 262,267,041.08 in the previous period[28] - Cash outflow from operating activities increased to 304,366,357.52 from 273,596,540.11 in the previous period[28] - Investment activities resulted in a net cash outflow of -72,655,965.56, compared to a net inflow of 3,407,723.78 in the previous period[28] - Financing activities generated a net cash inflow of 32,267,201.37, improving from a net outflow of -8,877,391.87 in the previous period[28] - The total cash and cash equivalents decreased by -150,487,903.07, compared to a decrease of -16,799,167.12 in the previous period[28] Investments and Acquisitions - The company plans to support its subsidiary Hangzhou Wanlin Shulian Technology Service Co., Ltd. in its overseas listing, with board approval obtained on April 26, 2024, and further investment decisions made on September 23, 2025[13] - The total investment for the construction of a smart ecological design R&D headquarters in Yuhang District is capped at 450 million yuan, with contracts signed with local authorities[14] - The company acquired 100% equity of Shanghai Manli Hotel Management Co., Ltd. for 2.46 million yuan, completing the equity change by the report date[17] - The company holds a 49% stake in Chengdu Yutingju Hotel Management Co., Ltd., which has been restructured as a wholly-owned subsidiary of Zhejiang Huize Engineering Design Co., Ltd.[18] - The company’s long-term equity investments increased to CNY 112,235,431.93 from CNY 110,131,205.94, a growth of 1.9%[20] Regulatory and Legal Matters - The company has received a warning letter from the Zhejiang Securities Regulatory Bureau, which has been addressed with corrective measures taken[17] - The company is currently processing foreign exchange procedures related to its overseas investment projects[13] - The company is involved in ongoing litigation regarding overdue payments, with several cases pending court decisions[16] - The company has successfully received a court ruling for 32,042,281.48 yuan in overdue payments from Qionghai Agricultural and Rural Bureau, with all principal amounts collected as of the report date[15] Shareholding Structure - The company’s major shareholders hold a combined indirect stake of 0.99% in the listed company through Hangzhou Yuanzhan Enterprise Management Co., Ltd.[12] - The company has no significant changes in the shareholding structure of the top 10 unrestricted shareholders due to securities lending activities[12] Research and Development - The company’s research and development expenses were CNY 6,988,535.78, down 34.3% from CNY 10,734,434.71 in the previous year[24] Miscellaneous - Short-term borrowings increased by ¥40 million, primarily due to bank loans taken during the reporting period[9] - The weighted average return on equity was 3.00%, an increase of 2.77% compared to the previous year[5] - The company did not undergo an audit for the third quarter financial report[30]
冠昊生物(300238) - 2025 Q3 - 季度财报
2025-10-28 08:15
Financial Performance - The company's revenue for Q3 2025 was ¥92,610,785.08, representing a 4.72% increase year-over-year[5] - Net profit attributable to shareholders decreased by 17.87% to ¥6,314,402.45 for the quarter[5] - The net profit after deducting non-recurring gains and losses surged by 358.61% to ¥6,016,683.90[5] - Total operating revenue for the third quarter reached ¥293,480,433.06, an increase of 5.8% compared to ¥278,135,520.40 in the previous year[19] - Net profit for the period was ¥20,429,167.53, slightly down from ¥20,658,923.30, indicating a decrease of 1.1%[20] - The company's gross profit margin was approximately 10.9%, compared to 10.2% in the previous year, showing an improvement[19] Assets and Liabilities - Total assets increased by 2.67% to ¥774,506,933.18 compared to the end of the previous year[5] - The total assets of the company increased to ¥774,506,933.18 from ¥754,399,831.41, representing a growth of 2.1%[17] - Current liabilities decreased to ¥152,297,698.75 from ¥177,990,961.77, a reduction of 14.5%[17] - Long-term borrowings rose significantly to ¥100,950,000.00 from ¥76,000,000.00, an increase of 32.5%[17] - The total equity attributable to shareholders increased to ¥572,121,327.51 from ¥542,358,105.24, reflecting a growth of 5.5%[17] Cash Flow - The company's cash flow from operating activities for the year-to-date reached ¥52,635,840.17, up 62.75%[5] - Net cash flow from operating activities increased to CNY 52,635,840.17, compared to CNY 32,342,033.71 in the previous period, reflecting a growth of 63.5%[23] - Cash inflow from operating activities totaled CNY 337,580,752.35, up from CNY 323,070,746.17, indicating a rise of 4.7%[22] - Cash outflow from investing activities was CNY 30,788,916.93, a decrease from CNY 60,133,403.09, showing a reduction of 48.8%[23] - Net cash flow from financing activities decreased to CNY 15,179,779.24 from CNY 35,785,043.84, a decline of 57.6%[23] - The ending balance of cash and cash equivalents increased to CNY 141,434,634.79 from CNY 104,349,485.07, reflecting a growth of 35.5%[23] - The company reported a net increase in cash and cash equivalents of CNY 36,950,834.68, compared to CNY 8,241,079.60 in the previous period[23] Shareholder Information - Total number of common shareholders at the end of the reporting period is 28,315[10] - The largest shareholder, Beijing Century Tianfu Venture Capital Center, holds 13.58% of shares, totaling 36,016,266 shares[10] - The second largest shareholder, Beijing Tianyou Ruiyuan Medical Technology Co., Ltd., holds 6.44% of shares, totaling 17,084,822 shares[10] - The third largest shareholder, Tibet Jingan Enterprise Management Consulting Co., Ltd., holds 3.77% of shares, totaling 10,000,000 shares[10] - Guangdong Zhiguang Biotechnology Co., Ltd. holds 2.76% of shares, totaling 7,310,000 shares, which are pledged[10] - The company has not reported any changes in the top 10 shareholders due to securities lending activities[11] Expenses and Financial Metrics - Financial expenses surged by 319.33% to ¥2,714,845.66 due to interest expenses from project-specific loans[8] - Other income decreased by 80.64% to ¥1,723,707.23, primarily due to reduced government subsidies[8] - Research and development expenses totaled ¥26,237,061.42, a decrease of 3.1% from ¥28,093,493.13 in the prior year[20] - The basic earnings per share for Q3 2025 was ¥0.0238, a decrease of 4.80%[5] - The weighted average return on equity was 1.13%, down 0.31% from the previous year[5] Other Information - The company reported a significant increase in prepayments by 265.73% to ¥7,589,380.81, attributed to increased procurement[8] - The company has a bank loan application of RMB 10 million (¥10,000,000) with China Industrial and Commercial Bank, guaranteed by its wholly-owned subsidiaries[12] - The company did not undergo an audit for the third quarter financial report[25] - The company plans to implement new accounting standards starting from 2025[24]
电光科技(002730) - 2025 Q3 - 季度财报
2025-10-28 08:15
Financial Performance - The company's operating revenue for Q3 2025 reached ¥286,122,264.72, representing a 9.43% increase year-over-year[5] - Net profit attributable to shareholders was ¥21,050,306.20, an increase of 11.53% compared to the same period last year[5] - The net profit for the current period is CNY 70,464,572.55, an increase from CNY 69,402,393.45 in the previous period, reflecting a growth of approximately 1.53%[18] - Operating profit for the current period is CNY 76,092,511.25, slightly up from CNY 75,045,849.59, indicating a growth of about 1.39%[18] - Total revenue from operating activities reached CNY 800,985,224.16, compared to CNY 751,991,018.91 in the previous period, marking an increase of approximately 6.4%[21] Profitability and Margins - The company reported a net profit margin improvement, with net profit increasing in line with revenue growth, although specific figures were not disclosed[16] - The net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 2.67% to ¥18,112,963.28[5] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥2,918,769,244.54, reflecting a 4.07% increase from the end of the previous year[5] - Total assets reached CNY 2,918,769,244.54, compared to CNY 2,804,515,351.38 at the beginning of the period, reflecting an increase of 4.1%[15] - Total liabilities amounted to CNY 1,216,573,621.77, up from CNY 1,127,393,007.66, which is an increase of 7.9%[15] - The company's total equity attributable to shareholders increased by 1.31% to ¥1,628,927,694.74[5] - The company's equity attributable to shareholders was CNY 1,628,927,694.74, compared to CNY 1,607,905,715.05, showing a growth of 1.3%[15] Cash Flow - The company's cash flow from operating activities showed a significant decline of 81.55%, totaling ¥16,804,086.34[9] - The cash flow from operating activities generated a net amount of CNY 16,804,086.34, a significant decrease from CNY 91,061,758.91 in the previous period[21] - Cash and cash equivalents net increase was ¥44,149,442.80, a 127.49% improvement compared to the previous year[9] - Cash and cash equivalents at the end of the period were CNY 407,438,914.48, an increase from CNY 365,564,373.69 at the beginning of the period, representing a growth of 11.9%[13] - The company reported a total cash and cash equivalents balance of CNY 401,348,678.25 at the end of the period, up from CNY 382,011,467.21[22] Investment and Expenses - Investment income surged by 2423.62% to ¥16,090,528.57, attributed to the sale of subsidiary equity[9] - The company incurred interest expenses of CNY 10,594,790.74, up from CNY 5,132,803.18, indicating an increase of about 106.5%[18] - The company reported a 236.04% increase in financial expenses, amounting to ¥3,445,973.33, primarily due to increased bank loan interest[8] - Research and development expenses increased to CNY 50,185,843.93 from CNY 49,488,817.70, reflecting a growth of approximately 1.4%[18] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 54,052, with the largest shareholder holding 44.19% of the shares[10] - Basic and diluted earnings per share remained stable at CNY 0.19 for both periods[18] Future Outlook - Future outlook includes plans for market expansion and potential new product launches, although specific details were not provided in the call[16]
浙江美大(002677) - 2025 Q3 - 季度财报
2025-10-28 08:15
Financial Performance - The company's operating revenue for Q3 2025 was ¥124,296,904.22, a decrease of 36.16% compared to the same period last year[5]. - The net profit attributable to shareholders for Q3 2025 was ¥5,612,152.92, down 37.91% year-on-year, while the net profit after deducting non-recurring gains and losses was ¥5,520,174.14, a decrease of 37.96%[5]. - For the first nine months of 2025, the total operating revenue was ¥336,581,164.82, representing a decline of 48.52% compared to the same period in 2024[8]. - Total operating revenue for the current period is ¥336,581,164.82, a decrease of 48.6% compared to ¥653,824,046.04 in the previous period[18]. - Net profit for the current period is ¥16,979,248.71, a decline of 83.8% from ¥104,867,245.96 in the previous period[19]. - Earnings per share for the current period is ¥0.03, compared to ¥0.17 in the previous period[20]. Cash Flow and Liquidity - Cash flow from operating activities for the first nine months of 2025 was a net outflow of ¥5,451,096.59, a decline of 127.03% compared to the same period last year[9]. - The net cash flow from operating activities was -5,451,096.59, compared to 20,164,191.76 in the previous period, indicating a significant decline[22]. - Total cash inflow from operating activities amounted to 376,050,424.19, while cash outflow was 381,501,520.78, resulting in a net cash flow deficit[22]. - The ending balance of cash and cash equivalents was 598,967,601.48, down from 825,300,272.88 at the beginning of the period, showing a decrease in liquidity[23]. - The company received 10,795,267.88 in cash related to operating activities, which is a decrease from 30,125,537.89 in the previous period[22]. - Payments to employees totaled 59,349,421.72, down from 82,438,812.23, indicating cost-cutting measures[22]. - The company reported cash outflows for taxes amounting to 40,545,445.30, compared to 100,140,448.30 previously, reflecting a decrease in tax liabilities[22]. Assets and Liabilities - The company's total assets as of September 30, 2025, were ¥1,619,055,059.82, a decrease of 13.97% from the end of the previous year[5]. - Total liabilities amount to ¥140,770,149.41, down from ¥227,214,660.56 in the previous period[17]. - Total equity attributable to shareholders of the parent company is ¥1,476,328,180.98, a decrease of 10.6% from ¥1,651,857,147.34 in the previous period[17]. - Cash and cash equivalents decreased from ¥920,481,983.34 to ¥598,967,601.48, a decline of approximately 35%[15]. - Accounts receivable increased from ¥12,375,431.91 to ¥17,000,336.55, representing a growth of about 37%[15]. - Inventory decreased from ¥49,940,593.89 to ¥45,943,005.35, a reduction of approximately 8%[16]. - Total assets decreased from ¥1,881,943,575.19 to ¥1,619,055,059.82, a decline of about 14%[16]. - Total non-current assets increased from ¥881,727,194.10 to ¥942,472,532.57, an increase of approximately 7%[16]. - Current liabilities decreased from ¥1,981,361.05 to ¥0 for accounts payable, indicating a significant reduction[16]. Investments - The company reported a significant increase in other equity instrument investments, rising by 1083.06% to ¥110,647,661.03, primarily due to investments in the automotive intelligent driving project[8]. - The net cash flow from investment activities was a net outflow of ¥106,443,116.12, a significant increase of 4813.91% compared to the previous year, attributed to investments in the automotive intelligent driving project[9]. - Cash flow from investing activities showed a net outflow of -106,443,116.12, compared to -2,166,158.00 previously, reflecting increased investment expenditures[22]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 61,219[11]. - The top three shareholders hold a combined 52.41% of shares, with Xia Zhisheng at 21.20%, Xia Ding at 20.99%, and Xia Lan at 10.22%[11]. - The company has no preferred shareholders as per the report[13]. - There are no significant changes in the top 10 shareholders' participation in margin trading[12]. Financial Reporting and Standards - The company did not undergo an audit for the third quarter financial report, which may affect stakeholder confidence[24]. - The company plans to implement new accounting standards starting in 2025, which could impact future financial reporting[24].
上能电气(300827) - 2025 Q3 - 季度财报
2025-10-28 08:15
上能电气股份有限公司 2025 年第三季度报告 证券代码:300827 证券简称:上能电气 公告编号:2025-083 上能电气股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会及董事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担 个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 一、主要财务数据 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 是 □否 追溯调整或重述原因 其他原因 | | | 上年同期 | | 本报告期 | | | | 年初至报 告期末比 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 本报告期 | | | 比上年同 期增减 | 年初至报 告期末 | 上年同期 | | 上年同期 增减 | | | | ...
利德曼(300289) - 2025 Q3 - 季度财报
2025-10-28 08:15
北京利德曼生化股份有限公司 2025 年第三季度报告 证券代码:300289 证券简称:利德曼 公告编号:2025-046 北京利德曼生化股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重 大遗漏,并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、完 整。 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年 | 年初至报告期 | 年初至报告期末 | | --- | --- | --- | --- | --- | | | | 同期增减 | 末 | 比上年同期增减 | | 营业收入(元) | 91,759,318.46 | -1.83% | 252,243,444.78 | -10.49% | | 归属于上市公司股东的净利润(元) | -2,889,611.78 | -720.79% ...
因赛集团(300781) - 2025 Q3 - 季度财报
2025-10-28 08:15
广东因赛品牌营销集团股份有限公司 2025 年第三季度报告 证券代码:300781 证券简称:因赛集团 公告编号:2025-078 一、主要财务数据 广东因赛品牌营销集团股份有限公司 2025 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整,不存在虚假记载、误导性陈述或重 大遗漏,并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明:保证季度报告中财务信息的真实、准确、 完整。 3.第三季度财务会计报告是否经过审计 □是 否 1 广东因赛品牌营销集团股份有限公司 2025 年第三季度报告 (一) 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末比上 年初至报告期末 | | | --- | --- | --- | --- | --- | | | | 增减 | 年同期增减 | | | 营业收入(元) | 204,343,287 ...
天府文旅(000558) - 2025 Q3 - 季度财报
2025-10-28 08:15
Financial Performance - The company's operating revenue for Q3 2025 was ¥22,064,119.67, a decrease of 9.15% compared to the same period last year, while year-to-date revenue increased by 69.32% to ¥226,280,801.59[5] - The net profit attributable to shareholders for Q3 2025 was -¥25,884,856.88, down 57.80% year-on-year, and the year-to-date net profit was -¥18,447,851.50, a decline of 108.64%[5] - The basic and diluted earnings per share for Q3 2025 were both -¥0.0201, representing a decrease of 58.27% compared to the same period last year[5] - The net loss for the current period was ¥12,532,257.19, compared to a net loss of ¥5,425,988.88 in the previous period, indicating a worsening of approximately 131.5%[35] - The company reported a basic and diluted earnings per share of -0.0143, compared to -0.0069 in the previous period, indicating a deterioration in earnings performance[36] Assets and Liabilities - The total assets at the end of Q3 2025 were ¥2,653,582,172.60, an increase of 11.76% from the end of the previous year[5] - The company's total assets increased to ¥2,653,582,172.60 from ¥2,374,406,051.04, marking a growth of about 11.7%[32] - Current liabilities totaled ¥516,538,221.92, up from ¥454,276,233.24, which is an increase of approximately 13.7%[32] - Non-current liabilities rose to ¥886,200,825.56 from ¥666,713,726.93, reflecting an increase of about 32.9%[32] - The total liabilities increased to ¥1,402,739,047.48 from ¥1,120,989,960.17, which is an increase of about 25.1%[32] - The total equity attributable to shareholders decreased to ¥1,048,742,646.30 from ¥1,063,231,206.36, a decline of approximately 1.4%[32] Cash Flow - The company’s cash flow from operating activities for Q3 2025 was -¥357,837,257.75, a significant decline of 945.56% year-on-year[10] - Operating cash inflow for the current period was CNY 372,210,781.32, compared to CNY 200,583,495.33 in the previous period, representing an increase of approximately 85.6%[37] - Operating cash outflow for the current period totaled CNY 730,048,039.07, significantly higher than CNY 234,807,838.56 in the previous period, indicating a rise of about 210.5%[38] - The net cash flow from operating activities was negative CNY 357,837,257.75, worsening from negative CNY 34,224,343.23 in the previous period[38] - Cash inflow from financing activities was CNY 588,468,274.32, up from CNY 125,000,000.00 in the previous period, marking an increase of about 370.5%[38] - The net cash flow from financing activities was positive CNY 398,904,361.85, compared to CNY 91,008,421.80 in the previous period, reflecting a significant increase of approximately 338.5%[38] Inventory and Expenses - The company reported a 298.72% increase in inventory, reaching ¥520,180,089.35, primarily due to increased production costs in the film and television projects[9] - The financial expenses surged by 555.71% to ¥18,721,273.97, attributed to increased loans related to film and television business[9] - Total operating costs increased to ¥235,018,203.69 from ¥141,461,378.79, reflecting a rise of about 66.1%[34] Shareholder Information - The total number of common shareholders at the end of the reporting period is 151,930[12] - Chengdu Sports Industry Investment Group holds 29.90% of shares, totaling 385,477,961 shares, with 192,738,980 shares pledged[12] Loans and Financing - The company approved a loan application of CNY 150 million at a fixed interest rate of 3.80% per annum for a term of 3 years, guaranteed by its indirect controlling shareholder[21] - The company applied for an additional loan of CNY 300 million from Chengdu Rural Commercial Bank at a rate of LPR + 70 basis points, and CNY 130 million from Industrial Bank at LPR + 50 basis points[23] - The company’s financial strategy includes utilizing loans for daily operations and project funding[21][23] Government and Compensation - The company received government subsidies amounting to ¥372,000.00 during the reporting period, with a total of ¥430,914.67 year-to-date[7] - The company received a compensation payment of 50,203,979.58 RMB from Rhine Group for the 2020 performance shortfall[15] - As of September 2023, the company received 26,194,996.70 RMB from the court related to the performance compensation[16] - The total amount of performance compensation received by the company is 54,163,271.02 RMB, including principal and interest[17] - The company received a total compensation of CNY 3,596,175.72 for land use rights due to the construction of Hangzhou Metro Line 3 Phase II[20] Strategic Initiatives - In August 2025, the company signed strategic cooperation framework agreements with multiple cultural and tourism organizations to promote diversified development[19] Related Party Transactions - The company signed service outsourcing contracts with related parties, including a project with Chengdu Talent Development Group[26] - The company’s subsidiary awarded a service outsourcing contract to Chengdu Cultural Tourism Property Management Co., Ltd., a related party[27] - The company is actively engaging in related party transactions to enhance operational efficiency[26][27] Transparency and Reporting - The company’s financial disclosures are available on major financial news platforms for transparency[22][28] - The company did not undergo an audit for the third quarter financial report[39]
东方材料(603110) - 2025 Q3 - 季度财报
2025-10-28 08:15
Financial Performance - The company's operating revenue for the third quarter was ¥104,709,092.58, a decrease of 11.06% compared to the same period last year[5] - The total profit for the third quarter was ¥4,279,391.80, down 53.83% year-on-year[5] - The net profit attributable to shareholders was ¥2,538,094.20, reflecting a decline of 63.82% compared to the previous year[5] - The basic earnings per share for the third quarter was ¥0.013, a decrease of 63.82% year-on-year[6] - Total operating revenue for the first three quarters of 2025 was CNY 279,113,930.51, a decrease of 7.4% compared to CNY 301,438,300.71 in the same period of 2024[20] - Net profit for the first three quarters of 2025 was CNY 3,192,518.86, a significant decline of 74.8% compared to CNY 12,696,986.43 in 2024[22] - Earnings per share for the first three quarters of 2025 were CNY 0.016, down from CNY 0.06 in the same period of 2024[22] - The company reported a total comprehensive income of CNY 3,192,518.86 for the first three quarters of 2025, compared to CNY 12,696,986.43 in 2024[22] Assets and Liabilities - The total assets at the end of the reporting period were ¥797,567,010.25, down 8.75% from the end of the previous year[6] - The company reported current assets totaling RMB 504,381,631.19 as of September 30, 2025, a decrease from RMB 561,790,933.16 as of December 31, 2024, representing a decline of approximately 10.2%[15] - Total liabilities decreased to RMB 101,552,320.19 from RMB 171,128,990.03, reflecting a significant reduction of approximately 40.6%[17] - The company's total assets were reported at RMB 797,567,010.25, down from RMB 874,012,497.83, a decrease of about 8.8%[16] - The company’s total liabilities and equity amounted to CNY 797,567,010.25, a decrease from CNY 874,012,497.83 in the previous year[18] Cash Flow - The cash flow from operating activities for the year-to-date was ¥9,442,738.65, a decrease of 56.96% compared to the previous year[5] - Operating cash flow for the first three quarters of 2025 was CNY 9,442,738.65, down 57.0% from CNY 21,937,415.40 in 2024[23] - Cash and cash equivalents amounted to RMB 186,307,144.78, showing a slight increase from RMB 182,272,276.84 year-over-year[15] - Cash and cash equivalents increased by CNY 8,855,422.51 in the first three quarters of 2025, compared to a decrease of CNY 70,542,509.69 in 2024[23] - The ending balance of cash and cash equivalents is $179,760,311.29, compared to $159,769,300.90 from the previous period, indicating an increase[24] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 28,565[12] - The shareholder structure indicates that the top ten shareholders hold a significant portion of the company's shares, with the largest shareholder owning 17,787,840 shares[14] Operational Insights - The company experienced a 42.52% decrease in receivables financing, primarily due to a reduction in notes receivable[9] - The company reported a 166.58% increase in contract liabilities, attributed to an increase in advance payments for contracts[9] - The company has no significant new product launches or technological developments mentioned in the conference call[14] - There are no plans for market expansion or mergers and acquisitions discussed during the call[14] - The company has not provided specific future guidance or performance outlook in the conference call[14] - Research and development expenses for the first three quarters of 2025 were CNY 12,991,046.46, slightly up from CNY 12,900,413.14 in 2024[20] Accounting Standards - The company will not apply the new accounting standards or interpretations starting from 2025[25]
佛慈制药(002644) - 2025 Q3 - 季度财报
2025-10-28 08:15
Revenue and Profit - The company's revenue for Q3 2025 was CNY 194,689,733.90, representing a decrease of 7.14% compared to the same period last year[5] - Total operating revenue for Q3 2025 was CNY 624,055,200.70, a decrease of 11.93% compared to CNY 708,531,496.45 in the same period last year[19] - Net profit attributable to shareholders increased by 167.92% to CNY 7,977,760.05, while the year-to-date net profit decreased by 2.54% to CNY 38,082,371.36[5] - Net profit for Q3 2025 was CNY 37,144,761.73, a decline of 8.99% compared to CNY 40,448,681.79 in Q3 2024[20] - The basic earnings per share for the current period was CNY 0.0156, up 168.97% year-on-year[5] - The company reported a basic and diluted earnings per share (EPS) of 0.0746 CNY, slightly down from 0.0765 CNY in the previous period[21] Cash Flow and Financial Activities - Cash flow from operating activities showed a significant increase of 677.92%, reaching CNY 93,505,221.89[12] - The net cash flow from operating activities was 93,505,221.89 CNY, a significant improvement compared to the previous period's negative cash flow of -16,179,550.59 CNY[21] - Total cash inflow from operating activities reached 615,352,024.64 CNY, up from 556,915,313.50 CNY in the prior period, indicating a growth of approximately 10.5%[21] - The net cash flow from investing activities was -17,798,690.52 CNY, worsening from -8,778,238.96 CNY in the prior period[22] - Cash flow from financing activities showed a net outflow of -23,933,988.62 CNY, an improvement from -29,460,365.54 CNY in the previous period[22] - The company received 14,000,000.00 CNY from borrowings, an increase from 10,000,000.00 CNY in the prior period[22] - The company paid 30,124,520.00 CNY in debt repayments, up from 23,400,000.00 CNY in the previous period[22] Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,523,957,908.79, an increase of 2.19% from the end of the previous year[5] - The company's total assets increased to CNY 2,523,957,908.79 in Q3 2025 from CNY 2,469,785,308.07 in Q3 2024, reflecting a growth of 2.20%[18] - Total liabilities rose to CNY 678,012,772.88 in Q3 2025, compared to CNY 654,805,874.66 in Q3 2024, marking an increase of 3.54%[18] - Deferred income tax assets increased to CNY 65,761,494.90 from CNY 61,809,926.77, showing a growth of 6.36%[18] Shareholder Information - The total number of common shareholders at the end of the reporting period is 33,288[13] - The largest shareholder, Lanzhou Foci Pharmaceutical Industry Development Group Co., Ltd., holds 61.63% of the shares, totaling 314,713,676 shares[13] - There are no significant changes in the top 10 shareholders' participation in margin trading[13] - The company remains unaware of any relationships among other shareholders beyond the known connections[13] Operating Costs and Expenses - Total operating costs for Q3 2025 were CNY 564,312,051.85, down 13.39% from CNY 651,587,799.98 year-over-year[19] - Research and development expenses for Q3 2025 were CNY 18,073,933.17, down 17.00% from CNY 21,768,633.09 in the previous year[19] - The company reported a decrease in sales expenses to CNY 72,223,250.25, down 22.36% from CNY 93,057,848.76 year-over-year[19] Other Financial Metrics - The company recorded a significant increase in other income, with operating income rising by 1202.37% to CNY 429,246.10 due to received compensation for penalties[11] - Financial expenses decreased by 40.20% to CNY -2,607,224.19, attributed to increased interest expenses from loans and reduced interest income from bank deposits[11] - The company has not reported any other non-recurring profit and loss items beyond those specified[6] - The company has no preferred shareholders as indicated in the report[15] - The company's long-term equity investments decreased to ¥50,048,818.67 from ¥55,663,345.27, a decline of about 10.9%[16] - Fixed assets decreased to ¥987,758,000.40 from ¥1,028,543,483.45, reflecting a reduction of approximately 4.0%[16] - The total current assets amounted to ¥1,322,828,440.81, up from ¥1,221,884,081.46, indicating a growth of approximately 8.3%[16] Audit Information - The company did not undergo an audit for the third quarter financial report[23]